Circulating Tumour Cells (CTCs) in Lung Cancer - biology, biomarkers and mouse models

Tue2  Sep10:00am(30 mins)
Charter 3


Enumeration of CTCs at baseline in NSCLC and SCLC provide prognostic information. In this presentation I will describe our current efforts to exploit CTCs to develop predictive biomarkers for personalised therapy, to discover more about the biology of metastasis, to reveal novel drug targets and to use CTCs to monitor the emergence of resistance to targeted therapies.
I will also describe the development of unique CTC derived mouse models that provide us with new opportunities to understand the biology SCLC, a disease where serial tumour biopsy is rarely obtained.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021